Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
gene therapy
genentech
4
×
life sciences
4
×
national blog main
biotech
fda
national
national top stories
new york top stories
san francisco top stories
boston blog main
boston top stories
cell therapy
clinical trials
new york blog main
novartis
san diego blog main
san diego top stories
san francisco blog main
acetylon pharmaceuticals
acute lymphoblastic leukemia
alector
alkermes
ambys medicines
avrobio
baricitinib
bcma
billy dunn
biogen
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
caribou biosciences
catalyst healthcare consultants
celgene
congress
constellation pharmaceuticals
crispr
darzalex
deals
What
new
4
×
fda
therapy
aiming
ambys
approved
atrophy
big
bio
biopharma
biotech
chemistry
cmc
congress
congressional
consistent
control
controls
crispr
daily
deadly
deal
debuted
diseases
drug
ensure
evrysdi
executives
feud
formed
friday
future
gene
green
group
home
intended
isn’t
known
lack
Language
unset
Current search:
genentech
×
new
×
" life sciences "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?